Aveanna Healthcare Holdings Inc (NASDAQ:AVAH) shares are trading lower by 26.2% at $3.98 after the company reported FY21 EPS results were down from last year. The company also issued FY22 sales guidance below analyst estimates.
Aveanna Healthcare reported quarterly losses of 69 cents per share. This is a 72.5 percent decrease over losses of 40 cents per share from the same period last year. The company reported $1.68 billion in sales this quarter. This is a 12% increase over sales of $1.50 billion in the same period last year. Aveanna Healthcare sees FY22 sales as low as $1.89 billion or as high as $1.92 billion, which is lower than the analyst consensus estimate of $2.02 billion.
